Catalog › ScriptLine › Unlock

Unlock the full ScriptLine dossier.

Your phone, answered right every time. Below is everything you get when you pay $5 to unlock the dossier for this idea: the schema you'd otherwise spend a week assembling yourself.

Adoptability 77/100 Build type: service business Category: healthcare Yr1 take-home (Fermi): $-23K
quick mvpopen marketdossier readytop pick

Before you unlock: common questions about this idea

Honest answers based on what the dossier actually says. No hype.

The upside might be too small to bother.
The Fermi model gives a year-1 take-home estimate, labeled as Fermi math. If the number doesn't justify your time, the dossier itself tells you so.
Why pay $5 if I can just ask ChatGPT?
ChatGPT will give you a starting point in 2 minutes. The dossier is 4-7 pages of structured product strategy: ICP by role, MVP scoped, 30/60/90 plan, financial model, outreach drip, and risk memo. If you've tried to outline a product with ChatGPT, you know the difference.
Will the idea actually work?
We don't know, and neither does anyone else who sells 'ideas'. What we promise is that the strategy is internally consistent, the math is checked, and the technology is buildable today. Most ideas in any portfolio fail; the survivors had taste, hustle, and timing.
See the structure first Back to landing page

30-day money-back guarantee. Terms.

Fermi math (estimate)

Yr1 ARR (low)
$60K
Yr1 ARR (high)
$540K
Yr1 take-home
$-23K

Land 60 pharmacies at $275/month and you've got $200k ARR - but HIPAA requirements, medication-name AI accuracy stakes, and notoriously slow-moving pharmacy owner buyers put realistic odds at 15%, yielding an expected year-one loss of ~$23k before you find your groove.

Estimates only. No live customer revenue claimed. The full model with editable assumptions is in the dossier.

What you'll see in the dossier

  • Buyer: the named ICP, the workflow, the budget line, the title that signs the check
  • Pain: the specific failure mode they hit today, in their words from skeptic-memo research
  • Why now: the market shift that makes this idea possible in 2026 and not 2022
  • MVP scope: a 5-page site map + the first 7 build tasks ranked by leverage
  • Stack recommendation: what to build it on (Wes-stack-aware: cPanel, Caddy, Postgres, iOS Swift, Remotion if needed)
  • 30/60/90 launch plan: what good looks like at each milestone and what to drop if you slip
  • Pricing model: three positions tested against the same buyer (annual/monthly/per-seat)
  • GTM channel: the one channel to win first, with the angle and the first 50 prospects
  • Outreach pack: the LinkedIn message, the email subject lines, the cold-call script
  • Email drip: day 0, 2, 5, 9, 14, 21 with full copy
  • Likely objections: the seven you'll hear most, with handled responses
  • Risk memo: what makes this idea fail honestly
  • Fermi financial model: three scenarios with the assumptions exposed and editable
  • "What we'd implement for you": the operator-partnership scope if you'd rather hire than build

Locked: full schema

ICP - named in this dossier

Dave Szymanski, Owner/Pharmacist at Szymanski Family Pharmacy (Dayton, OH) - read of Reliable, Aug 11 2026

What the product does

Your pharmacy closes at 6. But patients don't stop having questions at 6. Refill confusion, insurance problems, urgent symptoms - they call anyway, and nobody answers.

Unlock once, get the full dossier as a private URL plus a markdown download. $5 one-time.